Biologics

Biologics

A patient-focused platform for managing the financial, emotional, and physical burdens of cancer treatment.
  • Edit
DateInvestorsAmountRound
N/A

$840k

Early VC
N/A

$29.0m

Late VC

$1.2b

Valuation: $1.2b

Acquisition
Total Funding€27.1m

Recent News about Biologics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.